Main Article Content

Authors

Objective: To evaluate the prevalence of cardiovascular risk factors (CRF) and absolute risk (AR) among first-degree consanguinity relatives of Colombian patients with hypertension.
Methods: The study comprised 227 relatives (siblings and children of both sexes, between 12 and 40 years of age) and 204 hypertensive patients 34-84 years old from Quindío, Colombia. Lipid profile, glycemia, smoking, body mass index, and blood pressure were analyzed, and the AR of cardiovascular disease (CVD) to 10 years was estimated. Relatives were divided into two groups: GF1 relatives <18 years, GF2 relatives >18 years.
Results: three or more CRF were found in the three groups. The prevalence for smoking was 20.1%, 9.1%, and 15.9% in patients, GF1, and GF2, respectively. Hypercholesterolemia was 42.2%, 15.2%, and 18.6% in patients, GF1, and GF2, respectively. The prevalence of low HDL-c levels was 50.5%, 44.9%, and 63.6% in relatives, GF1, and GF2, respectively. Obesity was present alone in patients, (32.4%) and GF2 (10.8%). The AR was 19.6 and 6.4 in male and female patients, respectively; 0.31 and 0 in GF1 females and males, respectively, and in GF2 it was 1.5 and 0.15 in males and females, respectively.
Conclusions: Patients and relatives had more than three CRFs. HDL-c was low in all three groups. The AR was high in the young relatives. Programs are needed for weight, smoking, sedentary and dyslipidemia control to prevent or delay the development of CVD in relatives.

World Health Organization. The World Health report 2002:reducing risks, promoting healthy life. Geneva: WHO; 2002.p. 1-230.2.Ministerio de Salud, Instituto Nacional de Salud, Organiza-ción Panamericana de Salud.Situación de salud en Colombia.Indicadores básicos. Bogotá, DC: Ministerio de Salud, Insti-tuto Nacional de Salud, Organización Panamericana de Salud;2002.3.Aristizábal D, García E, McEwen J, Caulfield M, Méndez J,Medina E, et al. Bases genéticas de la hipertensión arterialesencial en Colombia: avances en nueve años de estudio. RevColomb Cardiol. 2006; 12: 409-30.4.Sistino JJ. Epidemiology of cardiovascular disease in the lastdecade: treatment options and implications for perfusion inthe 21st century. Perfusion. 2003; 18: 73-7.5.García G, Restrepo B,Trejos J,Landázuri, P. Homocysteine,folates and B12 vitamin in Colombian patients with coronarydisease. Arq Bras Cardiol. 2007; 89: 71-6.6.Landázuri P, Loango N, Gallego ML, Restrepo B. Diferenciasde sexo, edad y lípidos plasmáticos asociadas al polimorfismode la apolipoproteína E en un grupo de escolares de Quindío,Colombia. Biomedica. 2009: 29: 382-91.7.Uscategui-Peñuela RM, Álvares-Uribe MC, Leguado-SalinasI, Soler-Terranova W, Martínez-Maluendas L. Arias-ArteagaR, et al. Factores de riesgo cardiovascular en niños de 6 a 18 añosde Medellín, Colombia. An Pediat (Barc) 2004; 58: 411-7.8.Jaramillo NI, Torres-Galvis Y, Echevarría E, Llamas A, JiménezLP, Montoya, K, et al. Estudio sobre factores de riesgocardiovasculares en una población de influencia de la ClínicaLas Américas. Rev CESMed. 2004; 18: 9-18.9.Chobaniam AV, Bakris GL, Black HR, Cushman WC, GreenLA, Izzo JL, et al., and the National High Blood PressureEducation Program Coordinating Committee. The SeventhReport of the Joint National Committee on Prevention,Detection, Evaluation, and Treatment of High Blood Pressure.The JNC 7 Report. JAMA. 2003; 289: 2560-72.10. Chow CK, Jolly S, Rao-Melacini P, Fox KAA, Anand SS,Yusuf S. Association of diet, exercise, and smokingmodification with risk of early cardiovascular events afteracute coronary syndromes. Circulation. 2010; 121: 750-8.11. Bassuk SS, Manson JE. Epidemiological evidence for the roleof physical activity in reducing risk of type 2 diabetes andcardiovascular disease. J Appl Physiol. 2005; 99: 1193-204.12. National Cholesterol Education Program (NCEP). Expertpanel on detection, evaluation and treatment of high bloodcholesterol in adults (Adults Treatment Panel III). ThirdReport of the National Cholesterol Education program AdultTreatment III. JAMA. 2001; 285: 2486-98.13. World Health Organization. Definition, diagnosis andclassification of diabetes mellitus and its complications:Reportof a WHO Consultation. Part 1: Diagnosis and classificationof diabetes mellitus. Geneva: World Health Org; 1999.14. Friedewald WF, Levy RI, Fredrickson DS. Estimation of theconcentration of low-density lipoprotein cholesterol in plas-ma without use of the preparative ultracentrifuge. Clin Chem.1977; 18: 499-502.15. Grundy SM, Pasternak R, Greenland P, Smith S, Fuster V.Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: A statement for healthcareprofessionals from the American Heart Association and theAmerican College of Cardiology. J Am Coll Cardiol. 1999; 3:1348-59.16. Wilson PW, D ́Agostino RB, Levy D, Belanger AM,Silbershatz H, Kannel WB. Prediction of coronary heartdisease using risk factor categories. Circulation. 1998; 97:1837-47.17. Mendivil CO, Sierra ID, Pérez CE. Valoración del riesgocardiovascular global y prevalencia de dislipidemias según loscriterios del NCEP-ATP III en una población adulta de BogotáColombia. Clin Invest Arterioscl. 2004; 16: 99-107.18. Friedman GD, Selby JV, Quesenberry Jr CP, Armstrong MA,Klatsky AL. Precursors of essential hypertension: body weight,alcohol and salt use, and parental history of hypertension.Prev Med. 1988; 17: 387-402.

Colombia Médica Vol. 42 Nº 1, 2011 (Enero-Marzo)19. Lobstein LA. BaurPolicies to prevent childhood obesity in theEuropean Union. Eur J Public Health. 2005; 15: 576-9.20. Tafur LA, Ordoñes G, Millán JC, Varela JM, Rebellón P.Prevalencia de tabaquismo en estudiantes recién ingresados ala Universidad Santiago de Cali. Colomb Med. 2006; 37: 126-32.21. Johnson CC, Nicklas TA, Arbeit ML, Franklin FA, CresantaJL, Harsha DW, et al. Cardiovascular risk in parents ofchildren with elevated blood pressure. «Heart Smart»:familyhealth promotion. J Clin Hypertens. 1987; 3: 559-66.22. Reis EC, Kip KE, Marroquin OC, Kiesau M, Hipps Jr L,Peters RE. Screening Children to identify families at increasedrisk for cardiovascular disease. Pediatrics. 2006; 118: e1789-e97.23. Baena JM, Álvarez B, Piñol P, Martín R, Nicolau M, Altès A.Asociación entre la agrupación (clustering) de factores deriesgo cardiovascular y el riesgo de enfermedad cardiovascular.Rev Esp Salud Publica. 2002; 76: 7-15.24. Wang NY, Young JH, Meoni LA, Ford DE, Erlinger TP, KlagMJ. Blood pressure change and risk of hypertension associatedwith parental hypertension. The Johns Hopkins PrecursorsStudy. Arch Intern Med. 2008; 168: 643-8

Gallego, M. L., Loango, N., & Gallego, M. L. (2024). Cardiovascular risk factors in first-degree relatives of patients with hypertension*. Colombia Medica, 42(1), 17–25. https://doi.org/10.25100/cm.v42i1.747 (Original work published March 12, 2011)

Downloads

Download data is not yet available.